research funding database


Transthyretin Cardiac Amyloidosis Fellowship (USA)

Share this post

funding consultation boking
Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange play symbol appears between the two logos. An arrow mark points to the logos.

The Transthyretin Cardiac Amyloidosis Fellowship from Pfizer supports institutions with fellowship programs for cardiologists that have a strong focus on clinical practice, research, and education to further the understanding of transthyretin cardiac amyloidosis. Applications are open to accredited, USA-based academic institutions – this is an institutional grant and not open to individual applicants. The fellowship provides 80,000 USD for 1 year (no indirect costs).

Applications are due on June 20, 2024.

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

We value your opinion

Complete our 1-min user survey and receive complimentary full access to our premium research funding database.

Sign-up for our monthly
research funding newsletter

you can unsubscribe at any time